Myles Katz

Myles Katz is the Co-Founder and Director of Business Development at The Synthesis Institute, where he specializes in early-stage business strategy. He has successfully raised over $15 million for innovative business models, particularly focusing on the integration of psychedelic therapies into healthcare and wellness practices.1

Katz is also recognized for his involvement in advancing legal psychedelic initiatives, particularly in Oregon, where he serves as a licensed psilocybin facilitator. His work emphasizes socially responsible and green startups, aiming to educate people about transformative experiences through psychedelics.12

Throughout his career, Katz has worked on multiple continents and has been instrumental in launching and leading several venture capital-funded startups, demonstrating a strong commitment to innovation and sustainable practices in the business sector.13